LobbyingAlliance for Cell Therapy Now lobbying by quarter
Alliance for Cell Therapy Now's latest lobbying report covers Q3 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Alliance for Cell Therapy Now
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 4 |
| Q1 2023 | $50K | 4 |
| Q2 2023 | $40K | 4 |
| Q3 2023 | $20K | 2 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$80K · 17 reports
- Budget and appropriations$80K · 6 reports
- Medical research and clinical labs$0 · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES18 reports
- SENATE18 reports
- Natl Institutes of Health (NIH)7 reports
- Health & Human Services, Dept of (HHS)3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Todd Strategy Group | $80K | 4 quarters |
| Thorn Run Partners | $60K | 3 quarters |
| Hart Health Strategies | $20K | 3 quarters |
| Marchibroda Group | $0 | 12 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DANIEL M TODD | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid | Q3 2023 |
| JEFF LUCAS | Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent, Representative Larry Bucshon | Q3 2023 |
| NICHOLAS UEHLECKE | Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee | Q3 2023 |
| PAUL EDATTEL | Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg | Q3 2023 |
| BEAU SCHUYLER | Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre | Q2 2023 |
| PAUL BOCK | Counsel, Senate Judiciary Committee; Chief of Staff, Sen. Herb Kohl | Q2 2023 |
| ANDREW VOGT | Senate HELP Committee Senator Mark Kirk | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/10/18for Q3 2025 | Marchibroda Group | Under $5,000 |
| 25/10/18for Q2 2025 | Marchibroda Group | Under $5,000 |
| 25/10/18for Q1 2025 | Marchibroda Group | Under $5,000 |
| 25/10/18for Q4 2024 | Marchibroda Group | Under $5,000 |
| 25/10/18for Q3 2024 | Marchibroda Group | Under $5,000 |
| 24/06/29for Q2 2024 | Marchibroda Group | Under $5,000 |
| 24/06/29for Q1 2024 | Marchibroda Group | Under $5,000 |
| 24/06/29for Q4 2023 | Marchibroda Group | Under $5,000 |
| 24/01/16for Q3 2023 | Todd Strategy Group | $20K |
| 23/11/27for Q3 2023 | Marchibroda Group | Under $5,000 |
| 23/10/20for Q3 2023 | Todd Strategy Group | $20K |
| 23/10/16for Q2 2023 | Thorn Run Partners | $20K |
| 23/08/29for Q2 2023 | Hart Health Strategies | Under $5,000 |
| 23/07/21for Q2 2023 | Marchibroda Group | Under $5,000 |
| 23/07/20for Q2 2023 | Todd Strategy Group | $20K |
| 23/07/19for Q2 2023 | Thorn Run Partners | $20K |
| 23/06/19for Q1 2023 | Marchibroda Group | Under $5,000 |
| 23/04/20for Q1 2023 | Thorn Run Partners | $20K |
| 23/04/19for Q1 2023 | Todd Strategy Group | $20K |
| 23/04/13for Q1 2023 | Hart Health Strategies | $10K |